✦ LIBER ✦

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma

✍ Scribed by S. Jelić; V. Kovc̆in; N. Milanović; N. Babović; M. Kreac̆ić; Z. Ristović; M. Vlajić; I. Filipović-Ljes̆ković

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrogenic diabetes insipidus following

✍ P.A. Vasey; D.J. Dunlop; W.P. Steward 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Prognostic factors in advanced soft tiss

✍ Milanović, N.; Jelić, S.; Tomašević, Z.; Babović, N.; Kreačić, M.; Stamatović, L 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 302 KB

861 Treatment of advanced soft tissue sa

✍ M. Lopez; L. Serrone; S. Carpano; T. Gionfra; M. Rinaldi; P. Vici; L. Di Lauro; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Dose-intensive first-line chemotherapy w

✍ R Palumbo; C Neumaier; M Cosso; G Bertero; P Raffo; N Spadini; S Valente; G Vill 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High-dose chemotherapy consolidation for

✍ Bui-Nguyen, B.; Ray-Coquard, I.; Chevreau, C.; Penel, N.; Bay, J. O.; Coindre, J 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 391 KB

Feasibility and compliance of epirubicin

✍ R. Palumbo; S. Toma 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 231 KB